Cibc Private Wealth Group, LLC Intercept Pharmaceuticals, Inc. Transaction History

Cibc Private Wealth Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$88.49 - $127.55 $23,007 - $33,163	-260 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$60.0 - $85.67 $25,140 - $35,895	-419 Reduced 61.71%	260 $22,000
Q1 2018 May 17, 2018	BUY	$52.72 - $67.25 $21,298 - $27,169	404 Added 146.91%	679 $42,000
Q4 2017 Feb 12, 2018	BUY	$58.2 - $72.76 $16,005 - $20,009	275	275 $16,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.